BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37353784)

  • 21. Gene amplification-driven RNA methyltransferase KIAA1429 promotes tumorigenesis by regulating BTG2 via m6A-YTHDF2-dependent in lung adenocarcinoma.
    Zhang C; Sun Q; Zhang X; Qin N; Pu Z; Gu Y; Yan C; Zhu M; Dai J; Wang C; Li N; Jin G; Ma H; Hu Z; Zhang E; Tan F; Shen H
    Cancer Commun (Lond); 2022 Jul; 42(7):609-626. PubMed ID: 35730068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
    Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
    Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma.
    Tao X; Li Y; Fan S; Wu L; Xin J; Su Y; Xian X; Huang Y; Huang R; Fang W; Liu Z
    J Exp Clin Cancer Res; 2023 Jan; 42(1):12. PubMed ID: 36627670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RNA m
    Li Y; Sheng H; Ma F; Wu Q; Huang J; Chen Q; Sheng L; Zhu X; Zhu X; Xu M
    Cell Death Dis; 2021 May; 12(5):479. PubMed ID: 33980824
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N6-methyladenosine-regulated ADIRF impairs lung adenocarcinoma metastasis and serves as a potential prognostic biomarker.
    Teng Y; Zhao X; Xi Y; Fu N
    Cancer Biol Ther; 2023 Dec; 24(1):2249173. PubMed ID: 37700507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.
    Zhou Y; Shi X; Chen H; Mao B; Song X; Gao L; Zhang J; Yang Y; Zhang H; Wang G; Zhuang W
    Biomed Res Int; 2021; 2021():5557649. PubMed ID: 34337026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-485-5p Suppress the Malignant Characteristics of the Lung Adenocarcinoma via Targeting NADPH Quinone Oxidoreductase-1 to Inhibit the PI3K/Akt.
    Chen Y; Wu L; Bao M
    Mol Biotechnol; 2023 May; 65(5):794-806. PubMed ID: 36219369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA N6-methyladenosine reader IGF2BP2 promotes lymphatic metastasis and epithelial-mesenchymal transition of head and neck squamous carcinoma cells via stabilizing slug mRNA in an m6A-dependent manner.
    Yu D; Pan M; Li Y; Lu T; Wang Z; Liu C; Hu G
    J Exp Clin Cancer Res; 2022 Jan; 41(1):6. PubMed ID: 34980207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FBW7/GSK3β mediated degradation of IGF2BP2 inhibits IGF2BP2-SLC7A5 positive feedback loop and radioresistance in lung cancer.
    Zhou Z; Zhang B; Deng Y; Deng S; Li J; Wei W; Wang Y; Wang J; Feng Z; Che M; Yang X; Meng J; Li Y; Hu Y; Sun Y; Wen L; Huang F; Sheng Y; Wan C; Yang K
    J Exp Clin Cancer Res; 2024 Jan; 43(1):34. PubMed ID: 38281999
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway.
    Li Y; Huang H; Chen X; Yu N; Ye X; Chen L; Huang Z
    Tissue Cell; 2022 Dec; 79():101918. PubMed ID: 36148733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of metastasis-associated seven gene signature for predicting lung adenocarcinoma prognosis using single-cell RNA sequencing data.
    He J; Zhang W; Li F; Yu Y
    Math Biosci Eng; 2021 Jul; 18(5):5959-5977. PubMed ID: 34517518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decoding the multicellular ecosystem of lung adenocarcinoma manifested as pulmonary subsolid nodules by single-cell RNA sequencing.
    Xing X; Yang F; Huang Q; Guo H; Li J; Qiu M; Bai F; Wang J
    Sci Adv; 2021 Jan; 7(5):. PubMed ID: 33571124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
    Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
    BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
    Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of m
    Zeng QC; Sun Q; Su WJ; Li JC; Liu YS; Zhang K; Yang LQ
    Sci Rep; 2022 Nov; 12(1):20684. PubMed ID: 36450735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circular RNA CDR1-AS contributes to pemetrexed and cisplatin chemoresistance through EGFR/PI3K signaling pathway in lung adenocarcinoma.
    Mao Y; Xu R
    Biomed Pharmacother; 2020 Mar; 123():109771. PubMed ID: 31881486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasis-related long non-coding RNAs AL359220.1, SH3BP5-AS1 and ZF-AS1 are significant for prognostic assessment of lung adenocarcinoma.
    Tan J; Mao W; Long S; Zhang T
    Aging (Albany NY); 2023 Aug; 15(15):7551-7564. PubMed ID: 37566767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. m
    Yang X; Bai Q; Chen W; Liang J; Wang F; Gu W; Liu L; Li Q; Chen Z; Zhou A; Long J; Tian H; Wu J; Ding X; Zhou N; Li M; Yang Y; Cai J
    Adv Sci (Weinh); 2023 Jul; 10(20):e2206744. PubMed ID: 37171793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.